Skip to content
Professor Jonathan Carapetis holds separate qualifications as a medical practitioner (MBBS), specialist paediatric physician (FRACP Paediatrics), specialist infectious diseases physician (FRACP Infect Dis), and specialist public health physician (FAFPHM), as well as a PhD.
Between 1994-98 he conducted doctoral studies at the Menzies School of Health Research in Darwin into group A streptococcal diseases in the Aboriginal population, under the supervision of Bart Currie and John Mathews. This work translated into important public health interventions, including the establishment of Australia's first rheumatic heart disease control program in the Top End.
Returning to Melbourne in 1999, Professor Carapetis co-founded (with Prof Kim Mulholland) the Centre for International Child Health at the University of Melbourne Dept of Paediatrics. The Centre has since been recognised as the only Australian WHO Collaborating Centre in Child Health.
Professor Carapetis has been a Chief Investigator on grants worth more than $20 million since 2001, including three NIH grants, an NHMRC Centre for Clinical Research Excellence, and numerous NHMRC project grants. He was holder of an NHMRC Career Development Award and was granted the 2001 Australasian Society for Infectious Diseases / Glaxo SmithKline Award for Advanced Research in Infectious Diseases.
Jonathan was Director of the Menzies School of Health Research in Darwin until June, 2012, encouraging new directions for research, including the links between education and child health. In July, 2012 he took up the appointment of Director of the Telethon Institute for Child Health Research in Subiaco, Western Australia.
He has written numerous textbook chapters on rheumatic fever, has been an invited speaker at more than 30 national and international conferences, and has over 100 peer reviewed publications. Professor Carapetis' wide range of research interests includes group A streptococcal and pneumococcal diseases, other vaccine preventable diseases, vitamin D deficiency in refugees, and urinary tract infections in children.